Has Khalid Mohammed, DO received payments from drug or device companies?

Yes. Drug and device makers reported $33,974 in general payments to Khalid Mohammed, DO across 341 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khalid Mohammed, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khalid Mohammed, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khalid Mohammed, DO

Interventional Cardiology · Riverview, FLNPI 1740701093

Payments from drug & device makers

$33,974in general payments, 2019–2025

Across 341 payments — averaging $99.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$10K
Abbott$8K
Inari Medical, Inc.$3K
Boston Scientific$2K
Angiodynamics, Inc.$2K
Philips North America LLC$1K
plus $8K from 38 others

What the payments were for

Grants$2941%
Travel & lodging$16,75049%
Food & beverage$16,30848%
Education$6222%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	54	$9,819
Abbott	68	$8,207
Inari Medical, Inc.	35	$3,045
Boston Scientific	20	$2,351
Angiodynamics, Inc.	8	$1,741
Philips North America LLC	11	$1,128
Abiomed	13	$1,032
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	18	$678
Penumbra, Inc.	8	$638
Shockwave Medical, Inc	8	$611
Actelion Pharmaceuticals US, Inc.	5	$565
Asahi Intecc USA, Inc.	1	$448
Kestra Medical Technology Services, Inc.	8	$389
Contego Medical, Inc	2	$288
Johnson & Johnson	10	$288
AstraZeneca	10	$269
Stryker	5	$268
Argon Medical Devices, Inc.	4	$262
Cordis US CORP.	2	$195
Boehringer Ingelheim	4	$184
Chiesi USA, Inc.	5	$163
Pfizer	3	$154
Procyrion, Inc.	1	$138
W. L. Gore & Associates, Inc.	1	$119
Cardiovascular Systems Inc.	1	$116
Cardiva Medical, Inc.	3	$114
Amgen	7	$108
Inspire Medical Systems, Inc.	1	$86
Cathworks, Inc.	1	$84
Novo Nordisk	4	$84
Bard Peripheral Vascular, Inc.	3	$72
Merck	2	$39
Novartis	2	$35
Cardinal Health 200 LLC	2	$32
Terumo Medical Corporation	2	$32
Alnylam Pharmaceuticals Inc.	1	$29
Convatec Inc.	1	$26
Getinge USA Sales, LLC	1	$26
Atricure, Inc.	1	$25
Siemens Medical Solutions USA, Inc.	1	$21
Lantheus Medical Imaging, Inc.	1	$20
Astellas Pharma US Inc	1	$18
Teleflex LLC	1	$17
ZOLL Circulation Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

HawkOne$6,184
FLOWTRIEVER CATHETER, S$2,627
CT THROMBECTOMY SYSTEM KIT$2,627
XIENCE SKYPOINT$1,752
OPTIS$1,489
ESPRIT$1,422
TurboHawk$1,315
AngioVac$1,270
VersaCross Access Solution$784
PRESSUREWIRE$504
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$488
UPTRAVI$474
OPSUMIT$474
PERIPHERAL VASCULAR$448
US Und$436
AlphaVac$436
Impella$401
Indigo System$400
ENSITE$271
Omnilink Elite vascular stent system$254

How this compares

$33,974 in reported general payments places this provider in the 70th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$94,558

Medicare patients

233

Services billed

874

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	14	$65
Furosemide	11	$45

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Riverview

Dominick AngiolilloJacksonville$4M
Douglas SpriggsClearwater$3.2M
Rakesh PrashadOcala$3.1M
Aldo Martinez FleitesMiami Lakes$2.2M
Rohit AminPensacola$2M
Roberto CubedduNaples$2M
Arthur LeeGainesville$2M
Ruby SatpathyJacksonville$1.8M
Santhosh MathewsBradenton$1.7M
Pedro Martinez-ClarkMiami$1.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →